A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Assignment Study To Assess The Efficacy And Safety Of Reparixin In
Posted Date: May 15, 2019
- Investigator: Syed Ahmad
- Type of Study: Drug
The main purpose of this study is to evaluate the safety and effectiveness of the study drug in patients who have undergone pancreatic islet auto-transplantation.
Criteria:
To Be Eligible Patients Must Have Been Diagnosed With Chronic Pancreatitis And Are Scheduled To Have
Keywords:
Pancreatic Islet Aut, Chronic, Rep0112, Pancreatitis
For More Information:
Uc Cancer Center
513-584-7698
kastla@uc.edu